In 2026, Temazepam 20mg remains a widely recognized short-to-intermediate-acting benzodiazepine primarily prescribed for the short-term treatment of severe insomnia characterized by difficulty falling asleep, frequent awakenings, or early-morning waking. Marketed under brand names such as Restoril in some regions, this medication enhances GABA activity in the brain to produce sedative, anxiolytic, and muscle-relaxant effects, helping […]